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Abstract 
Genome-wide association studies (GWAS) have become a standard method for finding genetic 
variations that contribute to common, complex diseases. Recently, it is suggested that these 
diseases may be caused by epistatic interactions of multiple genetic variations. Although tens of 
software tools have been developed for epistasis detection, few are able to infer pathway 
importance from the identified epistatic interactions. AntEpiSeeker is originally an algorithm for 
detecting epistatic interactions in case-control studies, using a two-stage ant colony optimization 
(ACO) algorithm. We have developed AntEpiSeeker2.0, which extends the AntEpiSeeker 
algorithm to inference of epistasis-associated pathways, based on a natural use of the ACO 
pheromones. By looking at pheromone distribution across pathways, epistasis-associated 
pathways can be easily identified. The effectiveness of AntEpiSeeker2.0 in inferring epistasis-
associated pathways is demonstrated through a simulation study and a real data application. 
AntEpiSeeker 2.0 was designed to provide efficient inference of epistasis-associated pathways 
based on ant colony optimization and is freely available at 
http://lambchop.ads.uga.edu/antepiseeker2/. 
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Introduction 
Genome-wide association studies (GWAS) have become a standard method for finding genetic 
variations that contribute to common, complex diseases [1]. However, single locus analyses 
often do not reveal significant associations. Complex diseases have long been suspected to be 
caused by the joint effects of multiple genetic variations. The feature of such joint effects is that 
they may show little or no individual effect but strong interactions, which are often referred to as 
epistasis or epistatic interactions [2]. Recently, biological pathway analysis has become a popular 
approach to prioritize GWAS results [1, 3].   
However, epistatic interactions are often difficult to detect in GWAS due to computational 
intractability. Ant colony optimization (ACO) is an algorithm to solve difficult optimization 
problems such as the traveling salesman problem [4]. ACO simulates the positive feedback 
process that real-world ant colonies find the shortest path to a food source through 
communicating using pheromones. ACO has been successfully implemented in epistasis 
detection [5-7]. AntEpiSeeker1.0, a software tool for epistasis detection in GWAS based on a 
two-stage ACO algorithm, was shown to outperform its recent competitors based on a series of 
simulation studies and a real GWAS example [6]. Recently, a comparison study of five 
representative epistasis detection methods showed that AntEpiSeeker1.0 performed best on 
detecting epistasis displaying marginal effects and was an efficient and effective method in terms 
of overall performance [8]. 
Because of the existence of numerous correlated SNPs in a GWAS, there are often hundreds or 
thousands of, or even more SNP pairs showing epistatic interactions, most of which are false 
positives but difficult to prune out. To interpret the result of epistatic interactions, inference of 
epistasis-associated pathways could be a promising approach. In AntEpiSeeker algorithm, the 
pheromone of a SNP represents its information content, i.e. relative contribution to epistasis [6]. 
Simply but reasonably, the pheromone of a pathway can be approximated by the average 
pheromone of its associated SNPs, which provides a method for unbiasedly ranking the 
contribution of each investigated pathway to epistatic interactions. Based on this idea, we have 
developed AntEpiSeeker2.0, which provides efficient inference of epistasis-associated pathways. 
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Implementation 
Inference of pathway importance 
The procedure for epistasis detection employed by AntEpiSeeker algorithm is described in 
details in its 1.0 version [6]. In AntEpiSeeker2.0, once the ACO completes, the pheromone of 
each pre-defined pathway, defined as the average pheromone of its associated SNPs, is 
computed. All pathways are ranked in descending order of pheromones, where top ranked 
pathways are more likely to be associated with epistatic interactions. Note that not all SNPs in a 
pathway are informative because there can be many SNPs with random pheromones. To alleviate 
the effect of random SNP pheromones, the pathway pheromone may be computed from its top 
25% or 50% associated SNPs (ranked by SNP pheromones).   
Usage of AntEpiSeeker2.0 
AntEpiseeker2.0 was written in C++. GNU Scientific Library (GSL) needs to be installed on the 
user's computer before compiling. The parameters for executing the program should be specified 
in the “parameters.txt” file. The input SNP data should be tab-delimited, with the first row 
specifying the sample status (0 or 1). All subsequent rows should contain genotypes (coded by 0, 
1 and 2) for each SNP with the first column specifying SNP names. A tab-delimited pathway-
SNP association file should be also provided, where each row contains a pathway, with the first 
column showing the name of the pathway and the following columns showing its associated 
SNPs. There are four output files. "AntEpiSeeker.log" and “results_maximized.txt” record 
intermediate results and all detected epistatic interactions respectively, and two user-specified 
output files show the epistatic interactions with minimized false positives and sorted pathways 
with pheromones respectively. Parameter setting is described in the “readme” file. 
Results 
Simulation study 
To evaluate the performance of AntEpiSeeker2.0 on detecting epistasis-associated pathways, the 
real data based simulation presented by [6] was adopted and extended. The raw SNP data were 
the genotypes on human chromosome 1, retrieved from the 912 individuals of 11 populations in 
the International HapMap project (Phase 3) [9]. We removed the loci with missing genotypes or 
minor allele frequency<0.1, getting a total of 73,355 SNP markers for analysis. Because the 
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HapMap samples are not in case-control format, we randomly selected a half of samples as cases 
(the other half as controls). Then, we embedded 132 epistatic interactions with P-value<0.0001 
following 1) additive effects, 2) multiplicative effects and 3) threshold effects [10] into the data 
with randomly selected causative loci. Then, 200 pathways were simulated with each pathway 
consisting of 2~500 randomly selected non-causative SNPs. The 11th~14th pathways were 
selected as epistasis-associated pathways. 11th and 12th pathways were appended with 2~84 
within-pathway epistatic interactions respectively. 13th and 14th pathways were appended with 
2~84 cross-pathway epistatic interactions.  
50 datasets as described above were generated and AntEpiSeeker2.0 was then implemented with 
the following parameters: 5,000 ants, SNP set size [3, 6], 200 iterations for each SNP set size 
and initial pheromone=100. The result showed that 11th ~14th pathways ranked the top four 
pathways on all of the 50 datasets. To further test whether AntEpiSeeker2.0 assessed pathways 
without bias, all epistatic interactions were removed from the simulated data and we found that 
all pathways resulted in nearly equal pheromones after the ACO procedure, distinct from the 
pheromone distribution based on the datasets with epistatic interactions (Figure 1).  
Real data application 
AntEpiSeeker2.0 (parameters: 1000 iterations for each SNP set size and pathway pheromones 
computed from top half associated SNPs) was used to infer epistasis-associated pathways for the 
GWAS on rheumatoid arthritis (RA) from the Wellcome Trust Case Control Consortium 
(WTCCC) [11]. 235 KEGG human pathways [12] were assessed. SNPs were assigned to a gene 
if they were located between 1 kb upstream and downstream of the gene. To validate the result of 
epistasis-associated pathway inference, we compared the pheromones of top ranking pathways 
between real and permuted genotype data (Figure 2). The comparison suggests that there may be 
several tens of pathways associated with epistasis in RA. We found that top six pathways 
(~2.5%) showed highest biological relevance. There were two signaling pathways: notch and 
MAPK, which have been suggested to play an important role in progress of RA [13, 14]. The 
other four pathways were cardiac muscle contraction, hypertrophic cardiomyopathy, dilated 
cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, suggesting that RA is 
often accompanied by cardiovascular disorders [15]. 
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Discussion 
AntEpiSeeker belongs to stochastic optimization methods. Compared with brute-force 
optimization, AntEpiSeeker is much more efficient. For example, in the aforementioned 
simulation study, AntEpiSeeker identified 92 (69.9%) true epistatic interactions, while within the 
same computation time, brute-force optimization detected only one (0.7%) true epistatic 
interaction. 
Although tens of software tools have been developed for epistasis detection, few are able to 
relate identified epistasis to associated pathways. AntEpiSeeker2.0 was designed to provide 
efficient inference of epistasis-associated pathways. AntEpiSeeker2.0 itself does not incorporate 
a permutation procedure for assessing the significance of reported pathways, rending it able to 
report pathway ranking upon completion of the ACO procedure. However, AntEpiSeeker2.0 
reports a pheromone value for each pathway. To quickly determine whether the result of 
pathway inference is meaningful, users may simply plot pathway pheromones against their ranks 
/ IDs. Epistasis-associated pathways are expected to have obvious pheromone peaks, while non-
associated pathways are expected to have low and comparable pheromones. In addition, we have 
shown that AntEpiSeeker2.0 can unbiasedly assess pathways of different sizes (i.e. number of 
genes/SNPs in a pathway). Users may construct null distribution of pathway pheromones 
through applying AntEpiSeeker2.0 to permuted data (e.g. permuting the sample status) only for 
reconfirmation of the result of epistasis-associated pathway inference. 
Conclusions 
AntEpiSeeker2.0 has extended epistasis detection to epistasis-associated pathway inference, 
based on sorting pathway pheromones. In this study, AntEpiSeeker2.0 is shown to be effective in 
inferring epistasis-associated pathways based on a simulation study and a real data application. 
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Figure legends  
Figure 1. Comparison of pathway pheromones between the data with epistatic interactions 
and null data (averaged for 50 datasets). 
Figure 2. Comparison of pheromones of top ranking pathways between real and permuted 
WTCCC RA data (averaged for 20 permuted datasets). 
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Figure 1 
 
 
 
 
 
 
9 
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
12
.6
99
4.
1 
: P
os
te
d 
15
 M
ar
 2
01
2
Figure 2 
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